• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·603155.SS
Share

Xinyaqiang Silicon Chemistry Co.,Ltd Stocks

CN¥ 25.7Last Updated 13.07.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

CN¥ 1.32B

CN¥ 25.7
Key Takeaways

Risk factor

Weak & very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Headquartered in Suqian, China, Xinyaqiang Silicon Chemistry Co.,Ltd, founded in 2009, specializes in the production and distribution of organic silicon compounds, specifically methylsilane and phenyl derivatives. Their diverse product portfolio encompasses chemicals such as hexamethyldisiloxane, iodotrimethylsilane, chlorotrimethylsilane, hexamethyldisilane, diethoxydimethylsilane, dimethoxydimethylsilane, phenyltrichlorosilane, dichlorodiphenylsilane, dichlorodimethylsilane, trimethylethoxysilane, methyltrimethoxysilane, and methyltriethoxysilane. Additionally, they provide specialty silazanes and siloxanes, including 1,3-divinyltetramethyldisilazane, 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane, N,1,1,1-tetramethyl-N-(trimethylsilyl)silylamine, 1,1,1,3,3,3-hexamethyldisilazane, and 1,3-Bis(trimethylsilyl)urea.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.07.2026 15:34

Morning in New York: External Factors Heighten Risks

13.07.2026 14:37

Shares of L’Oréal’s small-cap partner have surged. It will go private

13.07.2026 13:45

SK Hynix Shares Have Their Worst Day Ever After a Record-Breaking U.S. Debut. Is It Time to Buy?

13.07.2026 13:09

Meta shut down its new AI photo-generation feature less than a week after its launch

13.07.2026 11:45

Wall Street's New Leaders: Who Will Succeed Buffett and Dalio?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026